Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2026-06-14 @ 1:15 AM
Study NCT ID:
NCT00524368
Status:
COMPLETED
Last Update Posted:
2013-02-15
First Post:
2007-08-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
Sponsor:
Tibotec Pharmaceuticals, Ireland
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Human Immunodeficiency Virus - Type 1 | View |